TGFB1 and inflammatory bowel disease: In contrast, stimulation of IBD LPMC with TGF-β1 neither inhibits NF-kB activation nor reduces the production of pro-inflammatory mediators, highlighting the possibility that IBD cells are resistant to TGF-β1-mediated immune suppression (70).